secwatch.observer — SEC 8-K summary
======================================

Issuer:     HARVARD BIOSCIENCE INC (HBIO)
CIK:        0001123494
Form:       8-K
Filed at:   2026-06-02T20:01:17+00:00
Accession:  0001171843-26-003877
Event type: other
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders approve 400,000-share increase in 2021 Incentive Plan and amendment to ESPP
--------------------------------------------------------------------------------

- Stockholders elected John Duke and Katherine A. Eade as Class II directors for three-year terms.
- Ratified Grant Thornton LLP as independent auditor for FY2026; 2,781,705 votes for, 13,975 against.
- Non-binding advisory vote approved named executive officer compensation: 1,768,695 for, 57,111 against.
- Amended ESPP increases authorized shares from 310,000 to 1,900,000 (approx. 1.59M share increase).
- Amended 2021 Incentive Plan increases authorized shares by 400,000 (from 646,520 available as of Dec 2025).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1123494/000117184326003877/0001171843-26-003877-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1123494/000117184326003877/f8k_060226.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-003877

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer